[ Price : $8.95]
FDA accepts for priority review a Replimune Group BLA for RP1 (vusolimogene oderparepvec) in combination with nivolumab for patien...[ Price : $8.95]
FDA lifts a clinical hold on an Amylyx Pharmaceuticals Phase 1 clinical trial of AMX0114, an investigational antisense oligonucleo...[ Price : $8.95]
Federal Register notice: FDA amends its regulations to reflect recent application-related actions for new animal drug applications...[ Price : $8.95]
FDA approves Amgens Lumakras (sotorasib) for use with its Vectibix (panitumumab) for adult patients with KRAS G12C-mutated metasta...[ Price : $8.95]
CDER posts its latest guidance agenda that shows it is committing to issuing 11 drug quality guidance documents in 2025.[ Price : $8.95]
An FDA update says contrary to an earlier alert, all new neonatal incubators currently supplied in the U.S. do not show concerning...[ Price : $8.95]
FDA grants AstraZeneca traditional approval for Calquence (acalabrutinib) with bendamustine and rituximab for adults with previous...